Low activity of O6-Methylguanine-DNA methyl-transferase (MGMT), was associated with a positive outcome in patients with aggressive pituitary adenomas treated with TMZ; so, it was postulated that the assessment of MGMT expression in tissue sample could be also useful in patients with NS to predict the future response to TMZ [42]. Here, MGMT is linked to pituitary gland adenoma.